A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
This study is currently recruiting participants.
Verified November 2017 by Genentech, Inc.
First Posted: October 29, 2008
Last Update Posted: November 14, 2017
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||September 21, 2022|
|Estimated Primary Completion Date:||September 21, 2022 (Final data collection date for primary outcome measure)|